Ms. Long is an expert in the economics and business strategy of innovation and growth. She has assisted executives in pharmaceuticals and biotechnology, consumer packaged goods, and information technology with maximizing the value of their products, services, and innovative technologies by addressing fundamental challenges related to research and development, business planning, opportunity assessment, and competitive market strategy. In health care, Ms. Long’s work has included projects for pharmaceutical and biotech manufacturers; joint ventures in research, teaching and patient care; academic medical centers; and general and specialty hospitals. For pharmaceutical manufacturers, Ms. Long’s work has encompassed pricing and managed markets strategy, account segmentation, and contracting recommendations for new and established brands; market research studies on branded product demand and launch strategy; pharmacoeconomic analyses of the value and impact of drug therapy; and forecasting and analytical modeling of growth opportunities and business options.
Articles in the National Law Review database by Genia Long